Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats.
7-methoxytacrine
Alzheimer’s disease
Tacrine
acetylcholinesterase inhibitors
blood biochemistry
blood-brain barrier
organ toxicity
Journal
Drug and chemical toxicology
ISSN: 1525-6014
Titre abrégé: Drug Chem Toxicol
Pays: United States
ID NLM: 7801723
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
pubmed:
2
7
2019
medline:
2
10
2021
entrez:
2
7
2019
Statut:
ppublish
Résumé
The search for tacrine derivatives, as potential Alzheimer´s disease treatment, is still being at the forefront of scientific efforts. 7-MEOTA was found to be a potent, centrally active acetylcholinesterase inhibitor free of the serious side effects observed for tacrine. Unfortunately, a relevant argumentation about pharmacokinetics and potential toxicity is incomplete; information about tacrine derivatives absorption and especially CNS penetration are still rare as well as detailed toxicological profile
Identifiants
pubmed: 31257938
doi: 10.1080/01480545.2019.1566350
doi:
Substances chimiques
Cholinesterase Inhibitors
0
Tacrine
4VX7YNB537
7-methoxytacrine
5778-80-3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM